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H5N1 Influenza A
Virus and Infected
Human Plasma
To the Editor: Since January
2004, a total of 22 persons have been
confirmed infected with avian
influenza A virus (H5N1) in Thailand;
14 of these patients died. Three waves
of outbreaks occurred during the past
2 years. The last patient of the third
wave was a 5-year-old boy whose
symptoms developed on November
28, 2005; he was hospitalized on
December 5 and died 2 days later. The
child resided in the Ongkharak
District, Nakhon Nayok Province, 70
km northeast of Bangkok. Villagers
informed the Department of
Livestock after the patient’s illness
was diagnosed. Five dead chickens
had been reported in this area from
November 28 to December 1, 2005.
Samples from these chickens could
not be obtained, thus, no H5N1 test-
ing was performed. The boy had
fever, headache, and productive
cough for 7 days before he was admit-
ted to the Her Royal Highness
Princess Maha Chakri Sirindhorn
Medical Center. Clinical examination
and chest radiograph showed evi-
dence of lobar pneumonia. He was
treated with antimicrobial drugs
(midecamycin and penicillin G) and
supportive care, including oxygen
therapy. On December 7, the patient’s
condition worsened, and severe pneu-
monia with adult respiratory distress
syndrome developed. Laboratory tests
showed leukopenia (2,300
cells/mm3), acidosis, and low blood
oxygen saturation by cutaneous pulse
oximetry (81.6%). Oseltamivir was
administered after his parents
informed hospital staff about the
boy’s contact with the dead chicken.
However, the boy died the same day;
no autopsy was performed. On
December 9, the cause of death was
declared by the Ministry of Public
Health to be H5N1 influenza virus. 
A blood sample was collected from
the patient on December 7; anticoagu-
lation was accomplished with ethyl-
enediaminetetraacetic acid (EDTA)
for repeated biochemistry analysis and
complete blood count. The plasma
from the EDTA blood sample was sep-
arated 2 days later and stored at –20°C
for 12 days. The sample was subse-
quently given to the Center of
Excellence in Viral Hepatitis, Faculty
of Medicine, Chulalongkorn
University, for molecular diagnosis
and then stored at –70°C, where spe-
cific precautions implemented for han-
dling highly infectious disease speci-
mens such as H5N1 influenza virus
were observed. Plasma was examined
by multiplex reverse
transcription–polymerase chain reac-
tion (RT-PCR) (1) and multiplex real-
time RT-PCR (2), both of which
showed positive results for H5N1
virus. The virus titer obtained from the
plasma was 3.08 × 103 copies/mL. The
plasma specimen was processed for
virus isolation by embryonated egg
injection, according to the standard
protocol described by Harmon (3).
Briefly, 100 µL 1:2 diluted plasma was
injected into the allantoic cavity of a
9-day-old embryonated egg and incu-
bated at 37°C. The infected embryo
died within 48 hours, and the allantoic
fluid was shown to contain 2,048
hemagglutinin (HA) units; also, sub-
type H5N1 was confirmed (1,2).
Whole genome sequencing was per-
formed and submitted to the GenBank
database under the strain
A/Thailand/NK165/05 accession no.
DQ 372591-8. The phylogenetic trees
of the HA and neuraminidase (NA)
genes were constructed by using
MEGA 3 (4) for comparison with
H5N1 viruses isolated from humans,
tigers, and chickens from previous
outbreaks in 2004 and 2005 (Figure).
The sequence analyses of the viruses
showed that the HA cleavage site con-
tained SPQRERRKKR, which dif-
fered from the 2004 H5N1 virus by an
arginine-to-lysine substitution at posi-
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tion 341. That finding had also been
observed in wild bird species during
earlier outbreaks in Thailand in 2004
(5). Similar to the 2004–2005 H5N1
isolates from Thailand, a 20–amino
acid deletion at the NA stalk region
was observed. Moreover, the amino
acid residues (E119, H274, R292, and
N294) of the NA active site were con-
served, which suggests that the virus
was sensitive to oseltamivir. In addi-
tion, a single amino acid substitution
from glutamic acid to lysine at posi-
tion 627 of PB2 showed increased
virus replication efficiency in mam-
mals (6).
Observing live influenza virus in
human serum or plasma is unusual.
However, in 1963, low quantities of
virus were isolated from blood of a
patient on day 4 of illness (7), and in
1970, the virus was cultivated from
blood specimens from 2 patients (8).
Recently, a fatal case of avian influen-
za A (H5N1) in a Vietnamese child
was reported. The diagnosis was
determined by isolating the virus from
cerebrospinal fluid, fecal, throat, and
serum specimens (9); viral RNA was
found in 6 of 7 serum specimens 4–9
days after the onset of illness (10). In
this case, the H5N1 virus could be
isolated from plasma on day 10 after
symptoms developed. This case
showed the virus in the patient’s
blood, which raises concern about
transmission among humans. Because
probable H5N1 avian influenza trans-
mission among humans has been
reported (11), this case should be a
reminder of the necessity to carefully
handle and transport serum or plasma
samples suspected to be infected with
H5N1 avian influenza. Because viable
virus has been detected in blood sam-
ples, handling, transportation, and
testing of blood samples should be
performed in a biosafety (category
III) containment laboratory to prevent
the spread of the virus to healthcare
and laboratory workers.
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Figure. Phylogenetic analysis of the hemagglutinin and neuraminidase genes of H5N1
from study patient compared with sequences from previous outbreaks (2004–2005). 
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